Company Results
Omaxe Q2 FY27: Standalone Profit ₹50.49 Cr, Consolidated Loss ₹25.14 Cr
Omaxe Ltd reported a standalone net profit of ₹50.49 crore and a consolidated net loss of ₹25.14 crore for the quarter ended 30 September 2026 (Q2 FY27). The results were placed before the board on 27 October 2026.
| Company | Omaxe Ltd (BSE scrip code 532880, NSE symbol OMAXE) |
|---|---|
| Period covered | Quarter and half year ended 30 September 2026 (Q2 and H1 FY27), unaudited |
| Board meeting date | 27 October 2026 |
| Standalone net profit, Q2 FY27 | ₹50.49 crore |
| Consolidated net loss attributable to owners, Q2 FY27 | ₹25.14 crore, against a loss of ₹166.61 crore in the same period a year earlier |
| SEBI order | Dated 24 September 2026, concerning non-compliance with Minimum Public Shareholding requirements |
| Company response to SEBI order | Evaluating legal remedies; the company does not expect a material impact on its financial position |
| Trading window | Closes 29 October 2026 |
What happened
Omaxe's board met on 27 October 2026 to consider and approve the unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The results notice was filed with the exchanges under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements (LODR) regulations.
Coverage of the filing reported a standalone net profit of ₹50.49 crore for Q2 FY27. That result turned the company from a loss in the year-ago period to a profit in the current quarter.
Standalone and consolidated figures
The company's standalone figures cover the parent company's own operations. The consolidated figures include its subsidiaries. In Q2 FY27 the two measures point in different directions:
- Standalone: net profit of ₹50.49 crore.
- Consolidated: net loss attributable to owners of ₹25.14 crore, compared with a loss of ₹166.61 crore in the corresponding period of the previous year. The loss narrowed sharply but did not turn to a profit.
Revenue figures for the quarter have been reported in differing amounts across coverage. This article does not state a revenue number until it can be checked against the exchange filing.
The SEBI order on public shareholding
On 24 September 2026, the Securities and Exchange Board of India (SEBI) passed an order against Omaxe concerning non-compliance with Minimum Public Shareholding (MPS) requirements. The order was reported alongside the Q2 results.
The company said it is evaluating legal remedies and does not expect a material impact on its financial position. Market commentary has pointed to the order and the consolidated loss as factors that continue to weigh on sentiment, while the standalone profit offers some relief.
Earlier FY27 results
The board approved Q1 FY27 results on 12 August 2026. The company reported Q1 revenue of ₹406 crore, against ₹282 crore in the year-earlier quarter, which is year-on-year growth of 43.9%. Net profit for the quarter was ₹1.30 crore. The Q1 standalone result showed a loss before tax of ₹40.82 crore and a net loss of ₹31.88 crore after tax benefits.
On 31 August 2026, the exchange sought clarification from Omaxe on a significant movement in its share price.
Background on the company
Omaxe was founded in 1987 by Rohtas Goel as a construction and contracting business. It was incorporated as Omaxe Builders Private Limited in 1989 and became a public limited company in 1999. The company is headquartered in New Delhi and has a presence across eight states.
Its first real estate project with executive floors was launched in Gurugram in 2001, and its first integrated township of 85 acres was built in Greater Noida in 2003. Omaxe reported delivered space of about 12.62 million square metres (around 136 million sq ft) as of March 2024. During FY 2024 it handed over 3.87 million square feet of space to customers.
What comes next
- 27 October 2026: board meeting to approve the Q2 and H1 FY27 unaudited results (standalone and consolidated). This has taken place.
- 29 October 2026: trading window closes.
- Pending: the company is evaluating legal remedies on the SEBI MPS order dated 24 September 2026. No timeline for that step has been set out in the filings reviewed.
Investors are likely to watch the company's response to the SEBI order and any further regulatory directives.
Frequently asked questions
What did Omaxe report for Q2 FY27?
Omaxe reported a standalone net profit of ₹50.49 crore and a consolidated net loss attributable to owners of ₹25.14 crore for the quarter ended 30 September 2026.
Why is the standalone result a profit when the consolidated result is a loss?
The standalone result covers only the parent company, while the consolidated result combines the parent with its subsidiaries. A profit at the parent level can coexist with a loss once subsidiaries are included.
What is the SEBI order against Omaxe about?
SEBI passed an order dated 24 September 2026 concerning non-compliance with Minimum Public Shareholding requirements. The company says it is evaluating legal remedies and does not expect a material impact on its financial position.
When did the board approve the results?
The board met on 27 October 2026 to approve the unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026.